Eucrisa

— THERAPEUTIC DISORDERS TREATED —
  • Atopic dermatitis

Eucrisa Generic Name & Formulations

General Description

Crisaborole 2%; oint.

Pharmacological Class

Phosphodiesterase 4 (PDE4) inhibitor.

How Supplied

Oint—60g, 100g

Manufacturer

Generic Availability

NO

Eucrisa Indications

Indications

Mild to moderate atopic dermatitis.

Eucrisa Dosage and Administration

Adults and Children

<3mos: not established. ≥3mos: apply a thin layer twice daily to affected areas.

Eucrisa Contraindications

Not Applicable

Eucrisa Boxed Warnings

Not Applicable

Eucrisa Warnings/Precautions

Warnings/Precautions

Not for ophthalmic, oral, intravaginal use. Discontinue immediately if hypersensitivity occurs. Pregnancy. Nursing mothers.

Eucrisa Pharmacokinetics

See Literature

Eucrisa Interactions

Eucrisa Adverse Reactions

Adverse Reactions

Application site pain (eg, burning, stinging); hypersensitivity reactions, contact urticaria.

Eucrisa Clinical Trials

See Literature

Eucrisa Note

Not Applicable

Eucrisa Patient Counseling

See Literature

Images